Please assess the completion status of the following clinical trial:

Trial Title: Use of Probiotic Lactobacilli for the Treatment of Lactational Mastitis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of mastitis~* Staphylococcal and/or streptococcal count higher than 3000 colony-forming units per ml of milk~* Milk leukocyte count higher 6 log10/mL~* Must be able to provide a milk sample without the aid of a milk pump~Exclusion Criteria:~* Mammary abscesses~* Any kind of parallel disease

- Gender: FEMALE
- Minimum Age: 19 Years
- Maximum Age: 38 Years
- Healthy Volunteers: f

Study Arms:
- Probiotic 1 (Type: EXPERIMENTAL): Women receiving Lactobacillus salivarius HN6
- Probiotic 2 (Type: EXPERIMENTAL): Women receiving Lactobacillus reuteri CR20
- Probiotic 3 (Type: EXPERIMENTAL): Women receiving Lactobacillus fermentum LC40
- beta-lactam (Type: ACTIVE_COMPARATOR): The evolution of the women ascribed to the other three arms will be compared with that of 100 women suffering lactational mastitis that will follow a conventional antibiotic treatment as prescribed by the pediatrician/gynecologist

Based on this trial design, predict the completion outcome and termination type (if applicable).